Veterinary Anti-infectives Market To Reach $11.93 Billion By 2030

Veterinary Anti-infectives Market Growth & Trends

The global veterinary anti-infectives market size is expected to reach USD 11.93 billion by 2030, registering a CAGR of 5.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. One of the most promising market drivers is the growing application and utilization of artificial intelligence (AI) to solve challenges in the veterinary sector. These activities, apart from the broader veterinary sector, are also happening in the field of veterinary anti-infectives.

A May 2024 study published by the Chinese Academy of Sciences and Newcastle University employed AI to uncover existing research gaps in antimicrobial research in multiple sectors like veterinary, medical, food safety, and environment. The study highlighted an important roadblock: a lack of collaboration, mainly in low-middle-income countries, regarding inter-sectoral research and development. Initiatives like this will boost the market by providing advanced knowledge about resistive infectious pathogens and promoting multi-sectoral research and development to tackle these complications.

In January 2023, the University of Nottingham invested over USD 2.0 million into a research project on rising resistance among infectious pathogens. The research project aims to study various crucial factors of infectious pathogens affecting humans and animals, such as genetic makeup, molecular interaction, and drug resistance pathways, using AI to discover novel therapeutic agents.

These factors promote the adoption of novel technologies to address the existing challenges in the veterinary anti-infectives industry and discover solutions to tackle them effectively. For instance, using AI to understand the infectious pathogens affecting animals on a structural and physiological level will assist researchers in designing specific drugs to combat them.

The rise in the integration of human & veterinary research also drives the market. This will encourage inter-sectoral research to develop novel drugs like antibiotics, anti-infectives, and antifungals amidst the growing drug resistance.

In January 2023, a leading drugs database that monitors drug approvals and stores drug information, Drug Central, enhanced its directory by integrating more than 154 veterinary drugs. This platform has 396 veterinary drugs classified based on factors like active pharmaceutical ingredients (APIs), pharmacological classification, drug indications, inter-sectoral drug use between human and veterinary, drug bioactivity, OTC, and prescription.

 Request a free sample copy or view report summary: Veterinary Anti-infectives Market Report

Veterinary Anti-infectives Market Report Highlights

• Based on animal type, the livestock segment accounted for the largest revenue share of 63.69% in 2023. Fish, poultry, swine, cattle, sheep, and goats are among the subcategories of the livestock segment. Growing everyday necessities, environmental sustainability, and rising meat consumption are all expected to contribute to this segment's significant expansion

• Based on product, the antibacterials segment dominated the market with a share of 51.38% in 2023, owing to rising infectious diseases among livestock & companion animals. Key antibacterial drugs produced especially for animal use include cephalosporins, tetracyclines, penicillin, macrolides, quinolones, sulfonamides, and polymyxins

• Based on the route of administration, the oral segment dominated the market with a revenue share of 71.00% in 2023 due to the simplicity of dosage administration. Additionally, since oral administration reduces the need for trips to veterinary clinics and hospitals, it helps prolong the action period

• Based on type, the OTC or over-the-counter segment dominated the market in 2023. Animal owners prefer these products because they are affordable, suitable for mild diseases, convenient, and accessible without a prescription from a veterinarian

• Based on distribution channel, the retail pharmacies segment dominated the market in 2023. This is explained by the accessibility and ease of delivery of immunizations and medications via retail pharmacies

• In 2023, North America accounted for the largest market share of 35.87%. The existence of well-established competitors and rising treatment costs among veterinary clinics are the primary drivers of the industry

• The Asia Pacific (APAC) market is growing due to the rising incidence of animal diseases, the growing concern for animal health, the increasing number of livestock, and the growing adoption of pets. A significant number of cattle and growing healthcare spending on veterinary care and animal health are additional significant factors anticipated to drive market expansion. For instance, nearly 30 percent of all cattle worldwide are found in China and India. The expanding population of livestock has boosted the demand for the production of meat and dairy products, which is predicted to fuel the demand for veterinary anti-infective for livestock animals

Veterinary Anti-infectives Market Segmentation

Grand View Research has segmented the global veterinary anti-infectives market based on animal type, product, route of administration, type, distribution channel & region:

Veterinary Anti-infectives Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

• Livestock Animal

  • Poultry

  • Swine

  • Cattle

  • Sheep & Goats

  • Fish

  • Others

• Companion Animal

  • Dogs

  • Cats

  • Others

Veterinary Anti-infectives Product Outlook (Revenue, USD Million, 2018 - 2030)

• Antimicrobial

  • Tetracyclines

  • Penicillin

  • Cephalosporins

  • Macrolides

  • Quinolones

  • Others

• Antifungals

• Antivirals

• Antiparasitic

• Others

Veterinary Anti-infectives Route Of Administration Outlook (Revenue, USD Million, 2018 - 2030)

• Oral

• Injectable

• Topical

Veterinary Anti-infectives Type Outlook (Revenue, USD Million, 2018 - 2030)

• OTC

• Prescription

Veterinary Anti-infectives Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital/ Clinic Pharmacy

• Retail Pharmacies

• E-commerce

Veterinary Anti-infectives Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • India

  • China

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Veterinary Anti-infectives Market

• Zoetis

• Boehringer Ingelheim

• Merck & Co. Inc.

• Dechra Pharmaceuticals Plc.

• Elanco Animal Health

• Ceva Sante Animale

• Virbac

• Biogénesis Bagó

• Vetoquinol

• Calier

• Norbrook Laboratories